Pharma-Bio Serv (PBSV) Change in Cash (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Change in Cash for 17 consecutive years, with -$4.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 23.82% year-over-year to -$4.0 million; the trailing twelve-month figure through Apr 2026 stood at -$301601.0 (up 78.71% YoY), and the FY2025 full-year result was -$3.4 million, up 7.9% from the prior year.
• Change in Cash slipped to -$4.0 million in Q2 2026 per PBSV's latest filing, from $2.4 million in the prior quarter.
• Across five years, Change in Cash topped out at $7.6 million in Q4 2023 and bottomed at -$7.2 million in Q1 2023.
• Historically, Change in Cash has averaged -$870937.3 across 5 years, with a median of -$177320.0 in 2022.
• The widest YoY moves for Change in Cash: up 3283.86% in 2023, down 586.3% in 2023.
• Over 5 years, Change in Cash stood at $223900.0 in 2022, then soared by 3283.86% to $7.6 million in 2023, then sank by 96.74% to $247174.0 in 2024, then tumbled by 334.06% to -$578540.0 in 2025, then plunged by 586.58% to -$4.0 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$4.0 million, $2.4 million, and -$578540.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.